Langerhans cell histiocytosis natural history: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 7: | Line 7: | ||
==Prognosis== | ==Prognosis== | ||
Excellent for single foci disease. | * Excellent for single foci disease. | ||
*With multi-focal disease 60% have a chronic course, 30% achieve remission and mortality is up to 10%<ref>{{cite journal |author=Komp D, El Mahdi A, Starling K, Easley J, Vietti T, Berry D, George S |title=Quality of survival in histiocytosis X: a Southwest Oncology Group study |journal=Med. Pediatr. Oncol. |volume=8 |issue=1 |pages=35-40 |year=1980 |pmid=6969347}}</ref>. | |||
==References== | ==References== | ||
Revision as of 19:37, 13 September 2012
|
Langerhans cell histiocytosis Microchapters |
|
Differentiating Langerhans cell histiocytosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Langerhans cell histiocytosis natural history On the Web |
|
American Roentgen Ray Society Images of Langerhans cell histiocytosis natural history |
|
Directions to Hospitals Treating Langerhans cell histiocytosis |
|
Risk calculators and risk factors for Langerhans cell histiocytosis natural history |
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Prognosis
- Excellent for single foci disease.
- With multi-focal disease 60% have a chronic course, 30% achieve remission and mortality is up to 10%[1].